factMR-logo.png
Metagenomic Sequencing Market Poised for 17.6% CAGR, Reaching US$ 7.1 Billion by 2033, States Fact.MR
September 12, 2023 09:00 ET | FACT.MR
Rockville, Sept. 12, 2023 (GLOBE NEWSWIRE) -- As per Fact.MR, a provider of market research and competitive intelligence, the global Metagenomic Sequencing Market is expected to rise at a CAGR of...
zion_logo_150x150.jpg
Global Ovarian Cancer Market Will Reach USD 4.01 Billion By 2024: Zion Market Research
August 14, 2018 12:00 ET | Zion Market Research
New York, NY, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Ovarian Cancer Market by Type (Epithelial Ovarian Tumors, Ovarian Germ Cell Tumors, Ovarian...
22157.jpg
Global Blood Brain Barrier (BBB Technologies) Market Report 2015-2030 - Novel CNS Drug Delivery Approaches
November 10, 2015 21:56 ET | Research and Markets
Dublin, Nov. 10, 2015 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/s29vbn/bbb_technologies) has announced the addition of the "BBB...
equities.com Announc
equities.com Announces Exclusive Video Interviews of Public Companies from 2014 Rodman & Renshaw Conference: INVT, LOCM, NVGN, RXII, SRNE
October 01, 2014 08:00 ET | Equities.com, Inc.
LOS ANGELES, Calif., Oct. 1, 2014 (GLOBE NEWSWIRE) -- equities.com, an online financial publication and social community for investors, has made available on its website exclusive video interviews...
Graham Kelly PhD, CEO & Chairman attended the Rodman & Renshaw 16th Annual Global Investment Conference
September 29, 2014 08:00 ET | Novogen Ltd
SYDNEY, Sept. 29, 2014 (GLOBE NEWSWIRE) -- Novogen Ltd. (ASX: NRT, NASDAQ: NVGN) Graham Kelly PhD, CEO & Chairman attended the Rodman & Renshaw 16th Annual Global Investment Conference where...
Amarantus Appoints I
Amarantus Appoints Iain Ross to Board of Directors
August 29, 2014 07:56 ET | Amarantus BioScience Holdings, Inc.
SAN FRANCISCO and GENEVA, Aug. 29, 2014 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the development of diagnostic and therapeutic...
Protea Announces Two
Protea Announces Two Additions to Its Board of Directors
February 06, 2013 08:00 ET | Protea Biosciences, Inc.
MORGANTOWN, W. Va., Feb. 6, 2013 (GLOBE NEWSWIRE) -- Protea Biosciences Group, Inc. ("Protea"), a leader in the field of bioanalytics, announced today that Thijs Spoor and Josiah T. Austin have been...
Novogen Ltd. (ADR) is Today's Focus Stock on MicroStockProfit.com
March 29, 2011 06:50 ET | MicroStockProfit.com
DALLAS, March 29, 2011 (GLOBE NEWSWIRE) -- MicroStockProfit.com announces an investment report featuring Novogen Ltd. (ADR) (Nasdaq:NVGN). The report includes financial, comparative and investment...
Novogen Appoints Three New Directors
September 20, 2010 08:00 ET | Novogen Limited
SYDNEY, AUSTRALIA--(Marketwire - September 20, 2010) -  Pharmaceutical development company, Novogen Limited (ASX: NRT) (NASDAQ: NVGN) has appointed three new Directors. Of the three...
Novogen Limited Receives Nasdaq Notice
July 23, 2010 08:00 ET | Novogen Limited
SYDNEY, AUSTRALIA--(Marketwire - July 23, 2010) -  Novogen Limited (ASX: NRT) (NASDAQ: NVGN) is listed on the Australian Stock Exchange and has an ADR program in place in the US through the...